Pages that link to "Q42604127"

The following pages link to Comparison of receptor binding characteristics of commonly used muscarinic antagonists in human bladder detrusor and mucosa. (Q42604127):

Displaying 12 items.

• Medical management of neurogenic bladder with oral therapy (Q26767313) (← links)
• The pharmacological rationale for combining muscarinic receptor antagonists and β-adrenoceptor agonists in the treatment of airway and bladder disease (Q26864937) (← links)
• Mirabegron: a Beta-3 agonist for overactive bladder (Q36160960) (← links)
• Role of fesoterodine in the treatment of overactive bladder (Q37283542) (← links)
• Fesoterodine for the treatment of overactive bladder (Q37634191) (← links)
• Pharmacologic therapy for the neurogenic bladder (Q37801062) (← links)
• Acetylcholinesterase Inhibitors and Drugs Acting on Muscarinic Receptors- Potential Crosstalk of Cholinergic Mechanisms During Pharmacological Treatment (Q38860110) (← links)
• Fesoterodine, its active metabolite, and tolterodine bind selectively to muscarinic receptors in human bladder mucosa and detrusor muscle (Q44348022) (← links)
• Modulation of lower urinary tract smooth muscle contraction and relaxation by the urothelium (Q59685348) (← links)
• Phencynonate S-isomer as a eutomer is a novel central anticholinergic drug for anti-motion sickness (Q61796454) (← links)
• Characterization of Muscarinic Receptors in the Human Bladder Mucosa: Direct Quantification of Subtypes Using 4-DAMP Mustard (Q84582381) (← links)
• Management of urinary incontinence (Q84757653) (← links)